Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Inventory: 2009-2025

Historic Change in Inventory for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -$257,000.

  • Rockwell Medical's Change in Inventory fell 180.56% to -$257,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year decrease of 361.73%. This contributed to the annual value of $332,000 for FY2024, which is 128.23% up from last year.
  • Per Rockwell Medical's latest filing, its Change in Inventory stood at -$257,000 for Q3 2025, which was up 70.96% from -$885,000 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Change in Inventory registered a high of $1.5 million during Q1 2022, and its lowest value of -$1.6 million during Q3 2023.
  • Over the past 3 years, Rockwell Medical's median Change in Inventory value was -$190,000 (recorded in 2024), while the average stood at -$247,182.
  • As far as peak fluctuations go, Rockwell Medical's Change in Inventory soared by 1,056.86% in 2022, and later tumbled by 999.30% in 2023.
  • Over the past 5 years, Rockwell Medical's Change in Inventory (MRQ) stood at $102,000 in 2021, then soared by 1,056.86% to $1.2 million in 2022, then tumbled by 67.37% to $385,000 in 2023, then plummeted by 99.74% to $1,000 in 2024, then tumbled by 25,800.00% to -$257,000 in 2025.
  • Its Change in Inventory was -$257,000 in Q3 2025, compared to -$885,000 in Q2 2025 and -$733,000 in Q1 2025.